Part 1: Disease of the Heart and Liver: A Relationship That Cuts Both Ways

Nicholas Scalzo1, Mehtap Canastar, Edward Lebovics

  • 1From the Department of Medicine, Section of Gastroenterology & Hepatobiliary Diseases, New York Medical College and Westchester Medical Center, Valhalla, NY.

Cardiology in Review
|December 18, 2020
PubMed

Insights

The heart and liver have complex interactions. Heart failure impacts the liver, while liver disease, like cirrhosis, affects the heart, influencing treatment and transplantation risks.

Area of Science:

  • Cardiology
  • Hepatology
  • Organ Interaction

Background:

  • The heart and liver exhibit intricate, bidirectional communication.
  • Liver disease can cause cardiac dysfunction, and heart failure can lead to hepatic injury.
  • Nonalcoholic fatty liver disease is linked to increased cardiovascular mortality.

Purpose of the Study:

  • To review the cardiac effects of liver disease and hepatic effects of heart disease.
  • To highlight how co-existing heart and liver conditions complicate management and increase transplantation risks.

Main Methods:

  • Literature review focusing on cardiac and hepatic interactions.
  • Analysis of disease mechanisms and clinical implications.
  • Discussion of management strategies in dual-organ involvement.

Main Results:

  • Acute and chronic heart failure can cause acute cardiogenic liver injury and congestive hepatopathy.
  • Cirrhosis can result in cirrhotic cardiomyopathy, including systolic/diastolic dysfunction and electrophysiological disturbances.
  • Management of either organ disease is altered by the presence of the other.

Conclusions:

  • Understanding the heart-liver axis is crucial for effective patient management.
  • Dual-organ involvement significantly increases risks for interventions like transplantation.
  • Expanding knowledge of heart-liver communication improves therapeutic approaches.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
106
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
84
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
304
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
481